Table Of Content

Psychopharmacology This journal was founded as Editors), J.O. Cole, J. Gerlach, M. Hamilton, J Robbins, D.R. Sibley, D.M. Warburton, H. de Wit Psychopharmacologia in 1959 and was renamed Leysen, F. Sulser. As of Vol. 85 (1985): H. Barry As of Vol. 142 (1999): P.J. Cowen, J. Gerlach, M.A Psychopharmacology beginning with Ill, D.E. Casey, J.O. Cole, J. Gerlach, $.D. Glick, Geyer, A.R. Green, J.H. Krystal, J. Leysen, K.A Vol. 46 (1976) A.R. Green,M . Hamilton, J.L eysen, T.W. Robbins, Miczek, T.W. Robbins, D.R. Sibley, D.M The journal has been edited by the following F. Sulser. As of Vol. 92 (1987): H. Barry III, D.E. Warburton, H. de Wit. As of Vol. 151 (2000): PJ Managing Editors: Casey, J.Gerlach, S.D. Glick, A.R. Green, J Cowen, J. Gerlach, M.A. Geyer, A.R. Green, J.H Leysen, T.W. Robbins, B.J. Spring, F. Sulser, D.M Krystal, K.A. Miczek, T.W. Robbins, D.R. Sibley, Vol. 1 (1959), E. Rothlin and A. Wikler; Vol. 2 Warburton. As of Vol. 98 (1989): H. Barry III, D.E D.M. Warburton, H. de Wit. As of Vol. 152 (2000) (1961), E. Rothlin and H. Isbell; Vol. 3 (1962), Casey, J. Gerlach, $.D. Glick, A.R. Green, J. P.J. Cowen, J. Gerlach, M.A. Geyer, A.R. Green, D E. Rothlin and A. Wikler: Vol. 4 (1963)—Vol Leysen, T.W. Robbins, D.R. Sibley, B.J. Spring, Hoyer, J.H. Krystal, K.A. Miczek, T.W. Robbins, (1965), J.O. Cole and E. Rothlin; Vol. 8 D.M. Warburton. As of Vol. 106 (1992): D.E. D.R. Sibley, D.M. Warburton, H. de Wit. As of Vol (1965)—Vol. 16 (1969), J.O. Cole, E. Jacobsen, Casey, J. Gerlach, M.A. Geyer, A.R. Green, J. 167/2 (2003): P.J. Cowen, M.A. Geyer, A.R. Green, M.E. Jarvik, M. Shepherd; Vol. 17 (1970), J.O. Leysen, K.A. Miczek, T.W. Robbins, D.R. Sibley, D. Hoyer, J.H. Krystal, K.A. Miczek, T.W Cole, E. Jacobsen, C. Kornetzky, M. Shepherd; B.J. Spring, D.M. Warburton. As of Vol. 109 Robbins, D.R. Sibley, D.M. Warburton, H. de Wit Vol. 18 (1970)-Vol. 27 (1972), J.O. Cole, M (1992): D.E. Casey, J. Gerlach, M.A. Geyer, A.R. As of Vol. 171/1 (2003): P.J. Cowen, V.H. Curran, Hamilton, E. Jacobsen, C. Kornetzky; Vol. 28 Green, J. Leysen, K.A. Miczek, T.W. Robbins, M.A. Geyer, A.R. Green, D. Hoyer, J.H. Krystal, (1973)—Vol. 35 (1974), J.O. Cole, M. Hamilton, E. D.R. Sibley, B.J. Spring, D.M. Warburton, H. de U.A. Miczek, T.W. Robbins, D.R. Sibley, D.M Jacobsen, C. Kornetzky, R.W. Russell; Vol. 36 Wit. Warburton, H. de Wit (1974)—Vol. 69 (1980), H. Barry III, J.O. Cole, ! As of Vol. 117 (1995): DE Casey, J. As of Vol. 172/1 (2004): P.J. Cowen, H.V. Curran, Hamilton, E. Jacobsen, R.W. Russell; Vol Gerlach, M.A. Geyer, A.R. Green, J. Leysen, M.A. Geyer, A.R. Green, D. Hoyer, J.H. Krystal, (1980)—Vol. 77 (1982), H. Barry III, J.O. Cole, ! K.A. Miczek, T.W. Robbins, D.R. Sibley, D.M. K.A. Miczek, T.W. Robbins, D.R. Sibley, H. de Wit Hamilton, T.W. Robbins, R.W. Russell Warburton, H. de Wit. As of Vol. 129 (1997): D.E Starting with Vol 80 (1983) the Editors have Casey, P.J. Cowen, J. Gerlach, M.A. Geyer, A.R. been: H Barry Ill, T.W. Robbins (Coordinating Green, J. Leysen, K.A. Miczek, W. Potter, T.W. Contents of Volume 175 - 2004 Abi-Dargham A — Frankle WG Blessing WW: Clozapine and olanzapine, Bruijn JA — Broek WW van den Adriani W > Laviola G but not haloperidol, reverse cold-induced Budde H > Smolka MN Aizenberg D — Barak Y and lipopolysaccharide-induced Burk JA — Kondrad RL Alleva E > Laviola G cutaneous vasoconstriction 487 Burton P > Parker LA Aloe L — Laviola G Body S —> Kheramin S Alting von Geusau N, Stalenhoef P, Boeckler F, Russig H, Zhang W, Lober S, Cabeza de Vaca S, Krahne LL, Carr KD: Huizinga M, Snel J, Ridderinkhof KR: Schetz J, Hiibner H, Ferger B, A progressive ratio schedule of Impaired executive function in male Gmeiner P, Feldon J: FAUC 213, self-stimulation testing in rats reveals MDMA (“ecstasy”) users 331 a highly selective dopamine D, receptor profound augmentation of Alvano A — Rampello L full antagonist, exhibits atypical d-amphetamine reward by food Amelsvoort T van — Haan L de antipsychotic properties in behavioural restriction but no effect of a Anderson IM — Kheramin S and neurochemical models of “sensitizing” regimen of d-amphetamine Anzivino LA — Jentsch JD schizophrenia 7 106 Araki H = Jin C Boilet V > Dias C Cador M — Dias C Araujo JA, Chan ADF, Winka LL, Bopp AC — Ferguson AR Caltagirone C — Spalletta G Seymour PA, Milgram NW: Bowen WD — Romieu P Campbell UC, Lalwani K, Hernandez L, Dose-specific effects of scopolamine Bradshaw CM — Kheramin S Kinney GG, Conn PJ, Bristow LJ: on canine cognition: Impairment Brand L — Harvey BH The mGluRS5 antagonist of visuospatial memory, but not Braus DF — Griisser SM 2-methyl-6-(phenylethyny!)-pyridine visuospatial discrimination 92 Bressan RA, Erlandsson K, Spencer EP, (MPEP) potentiates PCP-induced Ell PJ, Pilowsky LS: Prolactinemia is cognitive deficits in rats 310 Barak Y, Mirecki I, Knobler HY, Natan Z, uncoupled from central D,/D, dopamine Cangiano C — Frankle WG Aizenberg D: Suicidality and second receptor occupancy in amisulpride Canny BJ — Broadbear JH generation antipsychotics in treated patients 367 Carr KD — Cabeza de Vaca S schizophrenia patients: a case-controlled Bristow LJ — Campbell UC Cassel J-C — Jeltsch H retrospective study during a 5-year Broadbear JH, Nguyen T, Clarke IJ, Cebere A > Kosowski AR period 215 Canny BJ: Antidepressants, sex steroids Cebers G > Kosowski AR Benton D, Donohoe RT: The influence and pituitary — adrenal response in Cervenka S — Talvik M on cognition of the interactions sheep 247 Chan ADF — Araujo JA between lecithin, carnitine and Broek WW van den, Birkenhiager TK, Charney DS — Grillon C carbohydrate 84 Mulder PGH, Bruijn JA, Moleman P: Clarke IJ — Broadbear JH Bergman J — Czoty PW A double-blind randomized study Coghill DR — Rhodes SM Bertrand F — Jeltsch H comparing imipramine with fluvoxamine Conn PJ — Campbell UC Birkenhiger TK — Broek WW van den in depressed inpatients 481 Cordova J — Grillon C IV Cowen PJ — Mctavish SFB Garcia GG — Thomas JD Jeltsch H, Bertrand F, Galani R, Lazarus C, Czoty PW, Makriyannis A, Bergman J: Gil R > Frankle WG Schimchowitsch S, Cassel J-C: Methamphetamine discrimination and in Gill R > Spooren W Intraseptal injection of the 5-HT,,/5-HT vivo microdialysis in squirrel monkeys Gmeiner P — Boeckler F agonist 8-OH-DPAT and working 170 Goldberg SR — Harvey DM memory inrats 37 Goldberg SR — Stefanski R Jentsch JD, Anzivino LA: A low dose Dahl M-L — Melkersson KI Gomita Y — Jin C of the alpha, agonist clonidine Danion J-M — Pernot-Marino E Gorman JM — Frankle WG ameliorates the visual attention and Dar R, Frenk H: Smokers do not Grau JW — Ferguson AR spatial working memory deficits self-administer nicotine other than Grillon C, Cordova J, Morgan III CA, produced by phencyclidine in tobacco: a reply to Perkins (2004) Charney DS, Davis M: Effects administration to rats 76 259 of the beta-blocker propranolol on cued Jin C, Araki H, Nagata M, Suemaru K, Davis M — Grillon C and contextual fear conditioning in Shibata K, Kawasaki H, Hamamura T, Davis SA — Katner SN humans 342 Gomita Y: Withdrawal-induced Deakin JFW — Kheramin S Griisser SM, Wrase J, Klein S, Hermann D, c-Fos expression in the rat centromedial Dias C, Lachize S, Boilet V, Huitelec E, Smolka MN, Ruf M, Weber-Fahr W, amygdala 24 h following a single Cador M: Differential effects Flor H, Mann K, Braus DF, Heinz A: morphine exposure 428 of dopaminergic agents on locomotor Cue-induced activation of the striatum Jucaite A — Talvik M sensitisation and on the reinstatement and medial prefrontal cortex is Justinova Z — Stefanski R of cocaine-seeking and food-seeking associated with subsequent relapse behaviour 414 in abstinent alcoholics 296 Kapur S — Mamo D Djahanguiri B — Jafari MR Guo N —> Slifstein M Karow AC — Smolka MN Dominguez HD — Thomas JD Katner SN, Davis SA, Kirsten AJ, Donohoe RT — Benton D Haan L de, Amelsvoort T van, Rosien K, Taffe MA: Effects of nicotine and Durkin S — Russig H Linszen D: Weight loss after switching mecamylamine on cognition in rhesus from conventional olanzapine tablets monkeys 225 Easterling KW, Holtzman SG: In rats, to orally disintegrating olanzapine Kawasaki H — Jin C acute morphine dependence results in tablets 389 Kelley AE — Schochet TL antagonist-induced response suppression Hackett E > Frankle WG Kelsey JE, Mague SD, Pijanowski RS, of intracranial self-stimulation 287 Halldin C — Talvik M Harris RC, Kleckner NW, Matthews RT: Ell PJ — Bressan RA Hamamura T — Jin C NMDA receptor antagonists ameliorate Erlandsson K —> Bressan RA Hanson KL — Luciana M the stepping deficits produced by Harris RC — Kelsey JE unilateral medial forebrain bundle Farde L > Talvik M Harvey BH, Oosthuizen F, Brand L, injections of 6-OHDA in rats 179 Feifel D — Shilling PD Wegener G, Stein DJ: Stress-restress Kemp JA — Spooren W Feighner JP — Overstreet DH evokes sustained iNOS activity and Kheramin S, Body S, Ho M-Y, Feldon J — Boeckler F altered GABA levels and NMDA Velazquez-Martinez DN, Bradshaw CM, Feldon J — Russig H receptors in rat hippocampus 494 Szabadi E, Deakin JFW, Anderson IM: Ferger B — Boeckler F Harvey DM, Yasar S, Heishman SJ, Effects of orbital prefrontal cortex Ferguson AR, Patton BC, Bopp AC, Panlilio LV, Henningfield JE, dopamine depletion on inter-temporal Meagher MW, Grau JW: Brief Goldberg SR: Nicotine serves as an choice: a quantitative analysis 206 exposure to a mild stressor enhances effective reinforcer of intravenous Kinney GG — Campbell UC morphine-conditioned place preference drug-taking behavior in human cigarette Kirsten AJ > Katner SN in male rats 47 smokers 134 Kleckner NW — Kelsey JE Fernandez-Espejo E, Galan-Rodriguez B: Hayashi T — Stefanski R Klein S — Griisser SM Sensorimotor gating in mice is disrupted Hedelin G — Pernot-Marino E Knobler HY — Barak Y after AM404, an anandamide reuptake Heinz A — Griisser SM Kochan LD — Frankle WG and degradation inhibitor 220 Heishman SJ — Harvey DM Kollins SH — Fredericks EM Flor H — Griisser SM Henningfield JE — Harvey DM Kondrad RL, Burk JA: Transient Francés H, Smirnova M, Leriche L, Hermann D — Griisser SM disruption of attentional performance Sokoloff P: Dopamine D, receptor Hernandez L — Campbell UC following escalating amphetamine ligands modulate the acquisition Higgins GA — Spooren W administration in rats 436 of morphine-conditioned place Hlavka J — Overstreet DH Kosowski AR, Cebers G, Cebere A, preference 127 Ho A — Mantsch JR Swanhagen A-C, Liljequist S: Frankle WG, Gil R, Hackett E, Ho M-Y — Kheramin S Nicotine-induced dopamine release Mawlawi O, Zea-Ponce Y, Zhu Z, Hoenig K — Quednow BB in the nucleus accumbens is inhibited by Kochan LD, Cangiano C, Slifstein M, Holtzman SG — Easterling KW the novel AMPA antagonist ZK200775 Gorman JM, Laruelle M, Huang Y —> Slifstein M and the NMDA antagonist CGP39551 Abi-Dargham A: Occupancy of Hiibner H > Boeckler F 114 dopamine D, receptors by the atypical Huitelec E — Dias C Kozaric-Kovacic D — Pivac N antipsychotic drugs risperidone and Huizinga M — Alting von Geusau N Krahne LL — Cabeza de Vaca S olanzapine: theoretical implications Hulting A-L — Melkersson KI Kreek MJ — Mantsch JR 473 Hutchison KE, Rutter M-C, Niaura R, Kiihn K-U — Quednow BB Fredericks EM, Kollins SH: Assessing Swift RM, Pickworth WB, Sobik L: methylphenidate preference in ADHD Olanzapine attenuates cue-elicited Lachize S > Dias C patients using a choice procedure 39] craving for tobacco 407 Lalwani K — Campbell UC Freed JS — Overstreet DH Hwang D-R — Slifstein M Landry CF — Schochet TL Frenk H — Dar R Larsen N-E — Talvik M Fujiwara RA — Siuciak JA Jafari MR, Zarrindast MR, Djahanguiri B: Laruelle M —> Frankle WG Effects of different doses of glucose Laruelle M — Slifstein M Galani R — Jeltsch H and insulin on morphine state-dependent Laviola G, Adriani W, Rea M, Aloe L, Galan-Rodriguez B — Fernandez-Espejo E memory of passive avoidance in mice Alleva E: Social withdrawal, Garcia D > Romieu P 457 neophobia, and stereotyped behavior in developing rats exposed to neonatal Overstreet DH, Hlavka J, Feighner JP, Rosien K — Haan L de asphyxia 196 Nicolau G, Freed JS: Antidepressant-like Ruf M — Griisser SM Lazarus C — Jeltsch H effects of a novel pentapeptide, Russig H, Spooren W, Durkin S, Feldon J, Lee DY — Quinlan MG nemifitide, in an animal model of Yee BK: Apomorphine-induced Leriche L — Francés H depression 303 disruption of prepulse inhibition that can Liljequist S + Kosowski AR Ozmen L —> Spooren W be normalised by systemic haloperidol is Linszen D — Haan L de insensitive to clozapine pretreatment Liu J > Schulteis G Paine TA, Olmstead MC: Cocaine disrupts 143 Liber S —> Boeckler F both behavioural inhibition and Russig H — Boeckler F Luciana M, Hanson KL, Whitley CB: A conditional discrimination in rats 443 Rutter M-C — Hutchison KE preliminary report on dopamine system Panlilio LV — Harvey DM reactivity in PKU: acute effects of Parker LA, Burton P, Sorge RE, Schetz J — Boeckler F haloperidol on neuropsychological, Yakiwchuk C, Mechoulam R: Effect Schimchowitsch S — Jeltsch H physiological, and neuroendocrine of low doses of A’-tetrahydrocannabinol Schmidt LG — Smolka MN functions 18 and cannabidiol on the extinction Schochet TL, Kelley AE, Landry CF: of cocaine-induced and Differential behavioral effects of Maco M — Spooren W amphetamine-induced conditioned place nicotine exposure in adolescent and Mague SD — Kelsey JE preference learning in rats 360 adult rats 265 Maier W > Quednow BB Patton BC — Ferguson AR Schulteis G, Morse AC, Liu J: Makriyannis A — Czoty PW Perkins KA: Response to Dar and Frenk Conditioning processes contribute Mamo D, Sedman E, Tillner J, Sellers EM, (2004), “Do smokers self-administer to severity of naloxone-precipitated Romach MK, Kapur S: EMD 281014, pure nicotine? A review of the evidence” withdrawal from acute opioid a specific and potent SHT, antagonist in 256 dependence 463 humans: a dose-finding PET study 382 Pernot-Marino E, Danion J-M, Hedelin G: Sedman E + Mamo D Mann K —> Griisser SM Relations between emotion and Sellers EM — Mamo D Mannie ZN — Mctavish SFB conscious recollection of true and false Seymour PA — Araujo JA Mantsch JR, Yuferov V, autobiographical memories: an Sharf R — Quinlan MG Mathieu-Kia A-M, Ho A, Kreek MJ: investigation using lorazepam as a Shibata K — Jin C Effects of extended access to high pharmacological tool 60 Shilling PD, Melendez G, Priebe K, versus low cocaine doses on Pickworth WB —> Hutchison KE Richelson E, Feifel D: Neurotensin self-administration, cocaine-induced Pijanowski RS — Kelsey JE agonists block the prepulse inhibition reinstatement and brain mRNA levels Pilowsky LS — Bressan RA deficits produced by a 5-HT>,, and an o inrats 26 Pivac N, Kozaric-Kovacic D, agonist 353 Martin-Fardon R — Romieu P Muck-Seler D: Olanzapine versus Siuciak JA, Fujiwara RA: The activity Mashimo T — Ueta K fluphenazine in an open trial in of pramipexole in the mouse forced Mathieu-Kia A-M — Mantsch JR patients with psychotic combat-related swim test is mediated by D, rather than Matthews K — Rhodes SM post-traumatic stress disorder 451 D; receptors 163 Matthews RT — Kelsey JE Priebe K — Shilling PD Slifstein M, Hwang D-R, Huang Y, Guo N, Maurice T > Romieu P Sudo Y, Narendran R, Talbot P, Mawlawi O — Frankle WG Quednow BB, Kiihn K-U, Laruelle M: In vivo affinity of Mctavish SFB, Mannie ZN, Cowen PJ: Stelzenmueller R, Hoenig K, Maier W, ['*F]fallypride for striatal and Tyrosine depletion does not Wagner M: Effects of serotonergic extrastriatal dopamine D, receptors in cause depressive relapse in and noradrenergic antidepressants on nonhuman primates 274 antidepressant-treated patients 124 auditory startle response in patients Slifstein M — Frankle WG Meagher MW — Ferguson AR with major depression 399 Smirnova M — Francés H Mechoulam R — Parker LA Quinlan MG, Sharf R, Lee DY, Wise RA, Smolka MN, Budde H, Karow AC, Melendez G — Shilling PD Ranaldi R: Blockade of substantia nigra Schmidt LG: Neuroendocrinological Melkersson KI, Dahl M-L, Hulting A-L: dopamine D1 receptors reduces and neuropsychological correlates of Guidelines for prevention and treatment intravenous cocaine reward in rats 53 dopaminergic function in nicotine of adverse effects of antipsychotic dependence 374 drugs on glucose-insulin homeostasis Rampello L, Alvano A: Prediction of the Smolka MN — Griisser SM and lipid metabolism | response to citalopram and reboxetine in Snel J — Alting von Geusau N Meunier J — Romieu P post-stroke depressed patients: the Sobik L — Hutchison KE Milgram NW — Araujo JA reasons of the enrollment of patients Sokoloff P — Francés H Mirecki I — Barak Y without cognitive impairment 264 Sorge RE — Parker LA Moleman P —> Broek WW van den Ranaldi R > Quinlan MG Spalletta G, Caltagirone C: Global Mombereau C — Spooren W Rea M — Laviola G cognitive level and antidepressant Morgan III CA — Grillon C Rhodes SM, Coghill DR, Matthews K: efficacy in post-stroke depression 262 Morse AC — Schulteis G Methylphenidate restores visual Spencer EP > Bressan RA Muck-Seler D — Pivac N memory, but not working memory Spooren W, Mombereau C, Maco M, Mulder PGH — Broek WW van den function in attention deficit-hyperkinetic Gill R, Kemp JA, Ozmen L, disorder 319 Nakanishi S, Higgins GA: Nagata M > JinC Richelson E — Shilling PD Pharmacological and genetic evidence Nakanishi S — Spooren W Ridderinkhof KR indicates that combined inhibition Narendran R —> Slifstein M — Alting von Geusau N of NR2A and NR2B subunit containing Natan Z — Barak Y Riley EP — Thomas JD NMDA receptors is required to disrupt Nguyen T — Broadbear JH Romach MK — Mamo D prepulse inhibition 99 Niaura R — Hutchison KE Romieu P, Meunier J, Garcia D, Zozime N, Spooren W — Russig H Nicolau G —> Overstreet DH Martin-Fardon R, Bowen WD, Maurice Stalenhoef P — Alting von Geusau N Nordstr6m A-L — Talvik M T: The sigma, (6) receptor activation is Stefanski R, Justinova Z, Hayashi T, a key step for the reactivation of cocaine Takebayashi M, Goldberg SR, Su T-P: Olmstead MC — Paine TA conditioned place preference by drug Sigma, receptor upregulation Oosthuizen F — Harvey BH priming 154 after chronic methamphetamine Vi self-administration in rats: a study with Thomas JD, Garcia GG, Dominguez HD, Wrase J —> Griisser SM yoked controls 68 Riley EP: Administration of eliprodil Stein DJ — Harvey BH during ethanol withdrawal in the Yakiwchuk C — Parker LA Stelzenmueller R — Quednow BB neonatal rat attenuates ethanol-induced Yasar S — Harvey DM Su T-P —> Stefanski R learning deficits 189 Yee BK — Russig H Sudo Y — Slifstein M Tillner J + Mamo D Yuferov V — Mantsch JR Suemaru K —> Jin C Suzuki T > Veta K Uchida I > Ueta K Zarrindast MR — Jafari MR Swanhagen A-C — Kosowski AR Ueta K, Suzuki T, Uchida I, Mashimo T: Zea-Ponce Y — Frankle WG Swift RM — Hutchison KE In vitro inhibition of recombinant Zhang W — Boeckler F Szabadi E — Kheramin S ligand-gated ion channels by high Zhu Z — Frankle WG concentrations of milnacipran 241 Zozime N — Romieu P Taffe MA — Katner SN Takebayashi M — Stefanski R Velazquez-Martinez DN — Kheramin S Talbot P — Slifstein M Talvik M, Nordstrém A-L, Larsen N-E, Wagner M —> Quednow BB Jucaite A, Cervenka S, Halldin C, Weber-Fahr W — Griisser SM Farde L: A cross-validation study on the Wegener G — Harvey BH relationship between central D, receptor Whitley CB — Luciana M Indexed in/abstracted by Current Contents, occupancy and serum perphenazine Winka LL — Araujo JA Psychological Abstracts, Psyc INFO, concentration 148 Wise RA — Quinlan MG Index Medicus and in EMBASE